KAREN HOLDSWORTH: Open Payments
NPI 1104454842 · GRAHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,436 in 76 payments from 19 companies in 2025. Trend: 2023 $498 · 2024 $1,174 · 2025 $1,436
Food & beverage: $1,436
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $228 |
| AstraZeneca Pharmaceuticals LP | 9 | $204 |
| PFIZER INC. | 10 | $166 |
| Grifols USA, LLC | 4 | $106 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| ABBVIE INC. | 5 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $77 |
| Lilly USA, LLC | 4 | $72 |
Products named: AIRSUPRA, Wegovy, REXULTI, Prolastin-C Liquid, CAPLYTA, Ozempic, VRAYLAR, JARDIANCE.
Industry payments across NC — which companies pay providers there.
